Amany A. Azouz

814 total citations
32 papers, 642 citations indexed

About

Amany A. Azouz is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Amany A. Azouz has authored 32 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in Amany A. Azouz's work include Synthesis and biological activity (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Amany A. Azouz is often cited by papers focused on Synthesis and biological activity (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Amany A. Azouz collaborates with scholars based in Egypt, Saudi Arabia and United Arab Emirates. Amany A. Azouz's co-authors include Rania B. Bakr, Amira M. Abo‐Youssef, Mohamed A. Abdelgawad, Fares E.M. Ali, Adel G. Bakr, Ramadan A.M. Hemeida, Khaled R.A. Abdellatif, Gehan M. Kamel, El‐Shaymaa El‐Nahass and Phoebe F. Lamie and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Amany A. Azouz

31 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amany A. Azouz Egypt	15	336	144	133	65	61	32	642
Ahmed R. El‐Sheakh Egypt	15	136 0.4×	49 0.3×	149 1.1×	87 1.3×	42 0.7×	24	540
Humaira Zafar Pakistan	11	134 0.4×	39 0.3×	136 1.0×	35 0.5×	12 0.2×	79	423
Ahmed A.E. Mourad Egypt	12	132 0.4×	34 0.2×	211 1.6×	20 0.3×	29 0.5×	23	433
Paresh K. Patel India	11	252 0.8×	25 0.2×	145 1.1×	29 0.4×	56 0.9×	25	553
M. Heck Germany	11	70 0.2×	181 1.3×	210 1.6×	86 1.3×	34 0.6×	22	497
Longwang Chen China	16	112 0.3×	66 0.5×	247 1.9×	38 0.6×	20 0.3×	35	603
Minoru Tsuda-Tsukimoto Japan	9	169 0.5×	74 0.5×	193 1.5×	87 1.3×	7 0.1×	12	615
B. Kevin Park United Kingdom	11	53 0.2×	240 1.7×	142 1.1×	85 1.3×	61 1.0×	12	767
Kodihalli C. Ravindra United States	13	81 0.2×	77 0.5×	293 2.2×	43 0.7×	21 0.3×	22	699
Mei Su China	14	171 0.5×	69 0.5×	212 1.6×	16 0.2×	30 0.5×	36	559

Countries citing papers authored by Amany A. Azouz

Since Specialization

Citations

This map shows the geographic impact of Amany A. Azouz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany A. Azouz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany A. Azouz more than expected).

Fields of papers citing papers by Amany A. Azouz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amany A. Azouz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany A. Azouz. The network helps show where Amany A. Azouz may publish in the future.

Co-authorship network of co-authors of Amany A. Azouz

This figure shows the co-authorship network connecting the top 25 collaborators of Amany A. Azouz. A scholar is included among the top collaborators of Amany A. Azouz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amany A. Azouz. Amany A. Azouz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azouz, Amany A., et al.. (2025). Crafting cationic lecithmer nanocomposites as promising wagons for brain targeting of cinnamaldehyde: Accentuated neuroprotection via downregulation of Aβ1-42/p-tau crosstalk. Journal of Drug Delivery Science and Technology. 106. 106664–106664. 2 indexed citations

Azouz, Amany A., et al.. (2024). Investigating the tamoxifen/high-fat diet synergy: a promising paradigm for nonalcoholic steatohepatitis induction in a rat model. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 9067–9079. 1 indexed citations

Khalaf, Marwa M., et al.. (2024). Modulation of SIRT6 related signaling pathways of p-AKT/mTOR and NRF2/HO-1 by memantine contributes to curbing the progression of tamoxifen/HFD-induced MASH in rats. European Journal of Pharmacology. 984. 177069–177069.

Azouz, Amany A., et al.. (2024). Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration. Life Sciences. 355. 122995–122995. 1 indexed citations

Messiha, Basim Anwar Shehata, et al.. (2023). Lysosomal membrane stabilization by imipramine attenuates gentamicin-induced renal injury: Enhanced LAMP2 expression, down-regulation of cytoplasmic cathepsin D and tBid/cytochrome c/cleaved caspase-3 apoptotic signaling. International Immunopharmacology. 126. 111179–111179. 2 indexed citations

Azouz, Amany A., et al.. (2023). Management of ulcerative colitis by dichloroacetate: Impact on NFATC1/NLRP3/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification. Inflammopharmacology. 32(1). 667–682. 7 indexed citations

Messiha, Basim Anwar Shehata, et al.. (2023). Regulation of renal nitric oxide and eNOS/iNOS expression by tadalafil participates in the mitigation of amphotericin B–induced renal injury: Down-regulation of NF-κB/iNOS/caspase-3 signaling. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 3141–3153. 3 indexed citations

Azouz, Amany A., et al.. (2023). The enteroprotective effect of nifuroxazide against methotrexate-induced intestinal injury involves co-activation of PPAR-γ, SIRT1, Nrf2, and suppression of NF-κB and JAK1/STAT3 signals. International Immunopharmacology. 127. 111298–111298. 8 indexed citations

Abdel-Halim, M.Saeed, et al.. (2020). The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients. Kidney Research and Clinical Practice. 39(4). 479–486. 3 indexed citations

10.

Azouz, Amany A., et al.. (2020). Aliskiren, tadalafil, and cinnamaldehyde alleviate joint destruction biomarkers; MMP-3 and RANKL; in complete Freund's adjuvant arthritis model: Downregulation of IL-6/JAK2/STAT3 signaling pathway. Saudi Pharmaceutical Journal. 28(9). 1101–1111. 20 indexed citations

11.

Azouz, Amany A., et al.. (2020). Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2/HO-1, MAPK/NF-κB, and Bax/Bcl-2 signaling. Saudi Pharmaceutical Journal. 28(11). 1317–1325. 19 indexed citations

12.

Abo‐Youssef, Amira M., et al.. (2020). Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis. Life Sciences. 260. 118414–118414. 13 indexed citations

13.

Abo‐Youssef, Amira M., et al.. (2020). The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. Toxicology and Applied Pharmacology. 402. 115122–115122. 16 indexed citations

14.

Bakr, Rania B., et al.. (2019). Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bioorganic Chemistry. 88. 102964–102964. 30 indexed citations

15.

Abdelgawad, Mohamed A., Rania B. Bakr, & Amany A. Azouz. (2018). Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Bioorganic Chemistry. 77. 339–348. 66 indexed citations

16.

Ali, Fares E.M., Adel G. Bakr, Amira M. Abo‐Youssef, Amany A. Azouz, & Ramadan A.M. Hemeida. (2018). Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sciences. 207. 50–60. 52 indexed citations

17.

Ali, Fares E.M., Amany A. Azouz, Adel G. Bakr, Amira M. Abo‐Youssef, & Ramadan A.M. Hemeida. (2018). Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. Food and Chemical Toxicology. 120. 294–304. 57 indexed citations

18.

Lamie, Phoebe F., et al.. (2017). Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study. Journal of Enzyme Inhibition and Medicinal Chemistry. 32(1). 805–820. 51 indexed citations

19.

Elshemy, Heba A.H., et al.. (2016). Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC. European Journal of Medicinal Chemistry. 127. 10–21. 48 indexed citations

20.

Azouz, Amany A., et al.. (2015). Different Protective Effects of Trimetazidine against Renal Ischemia/Reperfusion Injury in Rats. 6(3). 64–69. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact